ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, P.
Right arrow Articles by Thomas, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, P.
Right arrow Articles by Thomas, P
Eur Respir J 2000; 16: 1008-1015
Copyright © ERS Journals Ltd 2000


Original Articles

Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate

PG Gibson, RL Henry, and P Thomas

Noninvasive markers of airway inflammation are needed for use in research and clinical practice in childhood asthma. Induced sputum and exhaled nitric oxide are well established as direct markers of inflammation for use in asthma research. Sputum can be induced from children of >6 yrs using inhalation of hypertonic saline, and, if appropriate, can be combined with an assessment of airway responsiveness to hypertonic saline. The success rate of sputum induction in children is 68-100%. Most studies have processed sputum using the plug selection method, and show that the dominant cell in sputum from normal children is the macrophage, and that the upper normal limit for sputum eosinophils in children is 2.5%. The inflammatory response in childhood asthma is characterized by elevated numbers of sputum eosinophils, and eosinophil cationic protein concentration, as well as increased nitric oxide and hydrogen peroxide levels in exhaled breath. Sputum eosinophils correlate with objective markers of disease severity in steroid-naive children with asthma, and in severe asthma. Inflammatory marker levels are lower in children using glucocorticosteroids. Induced sputum and exhaled gases are important markers of inflammation in childhood asthma. The clinical utility of these markers warrants further study.


This article has been cited by other articles:


Home page
ThoraxHome page
A M Li, E Hung, T Tsang, J Yin, H K So, E Wong, T F Fok, and P C Ng
Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea
Thorax, January 1, 2007; 62(1): 75 - 79.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. A. Birrell, K. McCluskie, E. Hardaker, R. Knowles, and M. G. Belvisi
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Eur. Respir. J., December 1, 2006; 28(6): 1236 - 1244.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste
Exhaled nitric oxide measurements: clinical application and interpretation
Thorax, September 1, 2006; 61(9): 817 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
L. G. Wood, M. L. Garg, R. J. Blake, S. Garcia-Caraballo, and P. G. Gibson
Airway and Circulating Levels of Carotenoids in Asthma and Healthy Controls
J. Am. Coll. Nutr., December 1, 2005; 24(6): 448 - 455.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre
Exhaled breath condensate: methodological recommendations and unresolved questions
Eur. Respir. J., September 1, 2005; 26(3): 523 - 548.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. MacGregor, S. Ellis, J. Andrews, M. Imrie, A. Innes, A. P. Greening, and S. Cunningham
Breath condensate ammonium is lower in children with chronic asthma
Eur. Respir. J., August 1, 2005; 26(2): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
R Ratnawati and P S Thomas
Exhaled nitric oxide in paediatric asthma
Chronic Respiratory Disease, July 1, 2005; 2(3): 163 - 174.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. G. Wood, M. L. Garg, J. L. Simpson, T. A. Mori, K. D. Croft, P. A. B. Wark, and P. G. Gibson
Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases
Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 426 - 430.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev, July 1, 2004; 84(3): 731 - 765.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A H Morice and J A Kastelik
Cough * 1: Chronic cough in adults
Thorax, October 1, 2003; 58(10): 901 - 907.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L P Malmberg, A S Pelkonen, T Haahtela, and M Turpeinen
Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma
Thorax, June 1, 2003; 58(6): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P G Gibson, J L Simpson, R Hankin, H Powell, and R L Henry
Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma
Thorax, February 1, 2003; 58(2): 116 - 121.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F L M Ricciardolo
Multiple roles of nitric oxide in the airways
Thorax, February 1, 2003; 58(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, M. Romagnoli, L. Corbetta, G. Casoni, K. Busljetic, G. Turato, G. Ligabue, A. Ciaccia, M. Saetta, and A. Papi
Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L.G. Wood, P.G. Gibson, and M.L. Garg
Biomarkers of lipid peroxidation, airway inflammation and asthma
Eur. Respir. J., January 1, 2003; 21(1): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L.-P. Boulet, V. Boulet, and J. Milot
How Should We Quantify Asthma Control?: A Proposal
Chest, December 1, 2002; 122(6): 2217 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Leader of the Working Group:, J.C. Kips, Members of the Working Group:, M.D. Inman, L. Jayaram, E.H. Bel, K. Parameswaran, M.M.M. Pizzichini, I.D. Pavord, R. Djukanovic, et al.
The use of induced sputum in clinical trials
Eur. Respir. J., July 1, 2002; 20(37_suppl): 47S - 50s.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. D. JONES, R. HANKIN, J. SIMPSON, P. G. GIBSON, and R. L. HENRY
The Tolerability, Safety, and Success of Sputum Induction and Combined Hypertonic Saline Challenge in Children
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1146 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.